As we found in our recent research, our brains also have powerful mechanisms for defending body weight – and can sort of ...

Monlunabant, a novel cannabinoid receptor 1 (CB1R) inverse agonist, led to significant weight loss compared with placebo in patients with obesity and metabolic syndrome over 16 weeks; however, ...

Weight loss drugs are proving to be super popular among many workers with job-based health insurance. But GLP-1 medications are busting their employers’ budgets, leading some firms to rethink ...